Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer

Clinical trial NCT03012230 · COMPLETED

Trial details

NCT number: NCT03012230
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Bone Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma

Start date: 2017-12-06
Primary completion: 2023-01-06
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.